Non-alcoholic fatty liver disease comprises a spectrum of diseases ranging from simple steatosis to non-alcoholic steatohepatitis, fibrosis, and cirrhosis. Probiotics have been proposed as a treatment option because of their modulating effect on the gut flora that could influence the gut-liver axis.However, the lack of randomised clinical trials makes it impossible to support or refute probiotics for patients with non alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis
LIRUSSI, FLAVIO;ORLANDO, ROCCO
2007
Abstract
Non-alcoholic fatty liver disease comprises a spectrum of diseases ranging from simple steatosis to non-alcoholic steatohepatitis, fibrosis, and cirrhosis. Probiotics have been proposed as a treatment option because of their modulating effect on the gut flora that could influence the gut-liver axis.However, the lack of randomised clinical trials makes it impossible to support or refute probiotics for patients with non alcoholic fatty liver disease and non-alcoholic steatohepatitis.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
